CU-06 is under clinical development by Curacle and currently in Phase I for Ulcerative Colitis. According to GlobalData, Phase I drugs for Ulcerative Colitis have an 82% phase transition success rate ...

Managing inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, may soon become more advanced and ...

Ulcerative Colitis companies are Janssen Pharmaceuticals, Takeda Pharmaceuticals, Pfizer, EA Pharma, Kissei Pharma, Gilead Sciences, Galapagos NV, Celgene (Bristol-Myers Squibb), AbbVie, Arena ...

Crohn's disease and ulcerative colitis are idiopathic ... important subsets of patients for whom the natural history of disease and response to treatment are predictable. The most widely held ...

The multicentre, prospective, cohort study by Ohad Atia and colleagues1 on the long-term efficacy and safety of maintenance vedolizumab in paediatric patients with inflammatory bowel disease (IBD) ...

Up to 25,000 people with ulcerative colitis (UC) in England could be in line for treatment with Pfizer’s once-daily oral therapy Velsipity, after NICE recommended its use by the NHS. The new ...

Crohn’s disease and ulcerative colitis (UC) are both types of inflammatory bowel disease (IBD) that share similar symptoms but differ in their affected areas, disease progression, and treatment ...

diff) is a bacterial infection that commonly affects people with ulcerative colitis (UC ... so you may need to change or intensify your treatment plan. People with UC and C.

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial EnrollmentPhase 3 ABTECT Trial evaluating obefazimod for moderately to severely active ...

Dear Dr Briffa, what can you suggest for ulcerative colitis? I am just recovering - hopefully - from a flare-up and would welcome any advice.